نام کاربری یا نشانی ایمیل
رمز عبور
مرا به خاطر بسپار
Tehran, March 16, IRNA – Phase one of a clinical trial for another Iranian COVID-19 vaccine, Fakhra – named after the martyred nuclear scientist Mohsen Fakhrizadeh – kicked off, with his son receiving the first dose. Organization of Defensive Innovation and Research, a department in Iran’s Defense Ministry, which was previously led by Dr. Mohsen […]
Tehran, March 16, IRNA – Phase one of a clinical trial for another Iranian COVID-19 vaccine, Fakhra – named after the martyred nuclear scientist Mohsen Fakhrizadeh – kicked off, with his son receiving the first dose.
Organization of Defensive Innovation and Research, a department in Iran’s Defense Ministry, which was previously led by Dr. Mohsen Fakhrizadeh, has developed the vaccine. Dr. Fakhrizadeh was assassinated on November 28.
The Fakhra vaccine Project Manager Dr. Karimi said in the unveiling ceremony that the efforts of the agency leading to the development of the vaccine started with manufacturing COVID-19 test kits and level-3 portable laboratories.
He said that research and development for the Fakhra vaccine began in December 2019, by collecting 35,000 samplings of the virus, from which 30 samples appropriate for initial vaccine seeds were isolated and cultivated.
Virus identification tests were then carried out and the final vaccine candid entered the trial production phase in June 2020, according to Karimi.
He also said that the vaccine then moved forward with other phases including animal tests and was finally given to Iran’s Food and Drug Administration which after some modifications licensed the vaccine to move with the clinical trial.
In the ceremony, Iran’s Health Minister Saeed Namaki also gave a speech, promising that Iran would soon become a world leader in producing the COVID-19 vaccine.
He underlined that Iran has managed to produce several vaccines for the Coronavirus, despite US sanctions pressure preventing the country from affording vaccines produced in other countries.
COVIran Barakat and Razi CovPars are other Iranian vaccines in the clinical trial phase, in addition to Soberana-02 which is a joint product of Cuba and Iran. There are also several other vaccines in the early stages of development.
این مطلب بدون برچسب می باشد.
Chairman of the Board of Directors of the Association of Iran’s Rubber and Tire Producers said 80 percent of the country’s needs for tires is met by domestic producers, IRIB reported
Iranian banking system paid 380.893 trillion rials (about $780 million) of facilities to knowledge-based companies in the first two months of the current Iranian calendar year (March 20-May 21), to register an over 100 percent rise compared to the same period in the preceding year
The production of iron ore concentrate in Iran increased by 17.6 percent in the first two months of the current Iranian calendar year (March 20 -May 20), as compared to the same period in the past year, according to the data released by the Iranian Steel Producers Association (ISPA)
The head of the Iran Airports and Air Navigation Company declared that the second FlightCheck aircraft arrived in the Islamic country after the finalization of the purchasing process and officially started its operation
Δ